Compare DVA & CSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DVA | CSL |
|---|---|---|
| Founded | 1994 | 1917 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Misc Health and Biotechnology Services | Specialty Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.9B | 15.3B |
| IPO Year | 2003 | 1994 |
| Metric | DVA | CSL |
|---|---|---|
| Price | $180.74 | $370.68 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 6 |
| Target Price | $156.75 | ★ $401.67 |
| AVG Volume (30 Days) | ★ 958.3K | 457.3K |
| Earning Date | 05-05-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 1.27% |
| EPS Growth | ★ N/A | N/A |
| EPS | 6.86 | ★ 9.37 |
| Revenue | ★ $13,643,069,000.00 | $5,003,600,000.00 |
| Revenue This Year | $3.85 | $2.59 |
| Revenue Next Year | $3.07 | $4.50 |
| P/E Ratio | ★ $26.11 | $40.09 |
| Revenue Growth | 6.46 | ★ 9.08 |
| 52 Week Low | $101.00 | $293.43 |
| 52 Week High | $247.49 | $432.91 |
| Indicator | DVA | CSL |
|---|---|---|
| Relative Strength Index (RSI) | 27.40 | 53.28 |
| Support Level | $176.59 | $324.65 |
| Resistance Level | $202.63 | $374.65 |
| Average True Range (ATR) | 8.14 | 12.14 |
| MACD | -5.52 | 1.11 |
| Stochastic Oscillator | 6.65 | 69.47 |
DaVita is one of the largest providers of dialysis services in the United States, boasting a market share of about 35%. The firm operates over 3,200 facilities worldwide, mostly in the US, and treats about 300,000 patients annually. Government payers dominate US dialysis reimbursement. DaVita receives about two-thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.
Carlisle Companies Inc is a holding company that manufactures and sells single-ply roofing products and warranted systems and accessories for the commercial building industry. It operates through two segments: Carlisle Construction Materials and Carlisle Weatherproofing Technologies. The majority of revenue comes from Carlisle Construction Materials, and more than half of total revenue is earned in the United States. Carlisle Construction Materials produces premium single-ply roofing products and warranted roof systems, including EPDM, TPO, PVC membrane, and polyiso insulation. Carlisle Weatherproofing Technologies produces building envelope solutions, including waterproofing, moisture protection products, air/vapor barriers, and spray polyurethane foam systems.